Program: Expanding access to new HPV screening for cervical cancer in rural Nigeria
Location: Osun State, Nigeria.
Overview: HPV vaccination does not cover all disease subtypes, are generally unavailable in many regions of the world, and does not eliminate risk for patients of certain age. This project is a community-anchored deployment of new HPV DNA genotyping tests that offer expanded coverage and accurate cervical screening of women ages 25-45 in two rural towns in Osun State, Nigeria.
Dr. Tajudeen Badmus, MD – Professor of Urology & Kidney Transplantation, Obafemi Awolowo University
Cervical Cancer Specialist:
Dr. Kayode Ajenifuja, MD – Professor of Gynecological & Preventive Oncology, Obafemi Awolowo University
Breast Cancer Specialists:
Dr. Adewale Aderounmu, MD – Consultant General Surgery, Obafemi Awolowo University
Clinical Partners – Cervical Cancer
Hopescan initiative inc.
Professor Kayode Olusegun Ajenifuja, MB.ChB, FWACS, FMCOG
Expertise: Professor of Obstetrics and Gynaecology at Obafemi Awolowo University (OAU), Professor Ajenifuja is a globally recognized authority on cervical cancer prevention. His research focuses on "Screen-and-Treat" models and the implementation of high-risk HPV DNA genotyping in low-resource settings. He provides the critical clinical link, ensuring all HopeScan participants have immediate access to specialized surgical and oncological care at OAUTH.
Dr. Akinfolarin Clement Adepiti, MB.ChB, FWACS, FMCOG
Expertise: Associate Professor and Honorary Consultant at OAUTHC with over 25 years of experience. Dr. Adepiti holds a Diploma in Cancer Prevention from the NIH (USA) and completed a Gynaecological Oncology Fellowship at the Roswell Park Cancer Institute (Buffalo, NY). He specializes in optimizing diagnostic techniques for pre-cancerous lesions and leads community-engaged screening programs that bridge the gap between rural outreach and hospital-based intervention.
Clinical Partners – Breast & Prostate Cancers
Hopescan initiative inc.
Professor Tajudeen O. Badmus, MB.ChB, FWACS
Expertise: Professor Tajudeen Badmus is a leading authority in Urological Oncology and Transplant Surgery in West Africa. His clinical and research focus centers on the early detection and surgical management of prostate cancer - the most prevalent cancer among Nigerian men. Professor Badmus has been instrumental in developing standardized protocols for prostate-specific antigen (PSA) screening and ultrasound-guided biopsies in resource-limited settings.
Dr. Adewale Aderounmu, MB.ChB, FWACS
Expertise: Dr. Adewale Aderounmu is a distinguished Surgical Oncologist and a key clinical lead in the HopeScan-OAUTH referral corridor. With extensive experience in the surgical management of solid tumors, his work is central to closing the gap between early detection and curative intervention. Dr. Aderounmu specializes in oncological resections and breast-conserving surgeries, focusing on improving survival outcomes for patients identified through community-based screening programs.
